Literature DB >> 12184549

Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention.

.   

Abstract

These guidelines for the treatment of patients who have sexually transmitted diseases (STDs) were developed by the Centers for Disease Control and Prevention (CDC) after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on September 26-28, 2000. The information in this report updates the 1998 Guidelines for Treatment of Sexually Transmitted Diseases (MMWR 1998;47 [No. RR-1]). Included in these updated guidelines are new alternative regimens for scabies, bacterial vaginosis, early syphilis, and granuloma inguinale; an expanded section on the diagnosis of genital herpes (including type-specific serologic tests); new recommendations for treatment of recurrent genital herpes among persons infected with human immunodeficiency virus (HIV); a revised approach to the management of victims of sexual assault; expanded regimens for the treatment of urethral meatal warts; and inclusion of hepatitis C as a sexually transmitted infection. In addition, these guidelines emphasize education and counseling for persons infected with human papillomavirus, clarify the diagnostic evaluation of congenital syphilis, and present information regarding the emergence of quinolone-resistant Neisseria gonorrhoeae and implications for treatment. Recommendations also are provided for vaccine-preventable STDs, including hepatitis A and hepatitis B.

Entities:  

Mesh:

Year:  2002        PMID: 12184549

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  117 in total

1.  Vulvovaginal candidiasis.

Authors:  Jeanne Marrazzo
Journal:  BMJ       Date:  2003-05-10

2.  Pilot study of COBAS PCR and ligase chain reaction for detection of rectal infections due to Chlamydia trachomatis.

Authors:  Matthew R Golden; Sabina G Astete; Rosa Galvan; Aldo Lucchetti; Jorge Sanchez; Connie L Celum; William L H Whittington; Walter E Stamm; King K Holmes; Patricia A Totten
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

3.  [European Association of Urology guidelines on urinary and male genital tract infections].

Authors:  P Schneede; A G Hofstetter; K G Naber; W Vahlensieck; M Ludwig; D Bach; H W Bauer; G Beyaert; H Blenk; Th Bootz; A Friesen; G Geiges; H-W Himstedt; W Hochreiter; H-J Keller; H-J Knopf; S Lenk; B Liedl; R Michaelis; L Neubauer; H Piechota; J Rassler; G Riedasch; K-H Rothenberger; K Rüdiger; H-J Schmitz; G Stadie; U Thiel; M C Truss; F M E Wagenlehner; W Weidner; M Westenfelder; B Göckel-Beining; A Heidenreich; H Rübben; K Schalkhäuser; W Thon; J W Thüroff; W Weidner
Journal:  Urologe A       Date:  2003-02-06       Impact factor: 0.639

4.  Current Issues in Screening for Chlamydia trachomatis.

Authors:  Robert L. Cook; Lars ØStergaard
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

5.  [Current developments in syphilis. Prevention].

Authors:  U Marcus; W Kiehl; O Hamouda
Journal:  Hautarzt       Date:  2003-11       Impact factor: 0.751

6.  Adolescent behaviour should be priority.

Authors:  Stephen J Genuis; Shelagh K Genuis
Journal:  BMJ       Date:  2004-04-10

7.  [Therapy of syphilis].

Authors:  M Hartmann
Journal:  Hautarzt       Date:  2004-02       Impact factor: 0.751

8.  Upsurge of genital Chlamydia trachomatis infection.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

9.  Adherence to hepatitis B virus vaccination at syringe exchange sites.

Authors:  Frederick L Altice; Robert D Bruce; Mary R Walton; Marta I Buitrago
Journal:  J Urban Health       Date:  2005-03-03       Impact factor: 3.671

10.  Inadvertent use of Bicillin C-R to treat syphilis infection--Los Angeles, California, 1999-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-03-11       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.